Bain Capital Life Sciences Fund L.P. 13D and 13G filings for Annexon, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:30 pm Sale | 2024-09-30 | 13G | Annexon, Inc. ANNX | Bain Capital Life Sciences Fund L.P. | 5,974,716 5.500% | -2,087,003 (-25.89%) | Filing |
| 2024-02-13 6:57 pm Purchase | 2023-12-31 | 13G | Annexon, Inc. ANNX | Bain Capital Life Sciences Fund L.P. | 8,061,719 11.000% | 5,121,092 (+174.15%) | Filing |
| 2023-05-30 5:00 pm Sale | 2023-05-25 | 13G | Annexon, Inc. ANNX | Bain Capital Life Sciences Fund L.P. | 2,940,627 5.500% | -1,945,989 (-39.82%) | Filing |
| 2023-02-14 06:41 am Purchase | 2022-12-31 | 13G | Annexon, Inc. ANNX | Bain Capital Life Sciences Fund L.P. | 4,886,616 11.000% | 1,945,989 (+66.18%) | Filing |
| 2021-02-16 3:21 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Bain Capital Life Sciences Fund L.P. | 2,940,627 7.700% | 2,940,627 (New Position) | Filing |